Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.56 |
| ▸ | APP | P05067 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23836832 | 0.98 | MAPT (0.52) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL14762765 | 0.87 | MAPT (0.61) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL20718538 | 0.83 | MAPT (0.56) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL11936953 | 0.83 | MAPT (0.74) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL20718508 | 0.82 | MAPT (0.70) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL28643094 | 0.81 | MAPT (0.52) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL23836806 | 0.80 | MAPT (0.39) | MAPTAPPALDH1A1KDM4E | |
| SCHEMBL23836819 | 0.80 | MAPT (0.39) | MAPTAPPALDH1A1KDM4E | |
| SCHEMBL20717958 | 0.79 | MAPT (0.36) | MAPTAPPMEN1KMT2AALDH1A1 | |
| SCHEMBL29898512 | 0.79 | MAPT (0.56) | MAPTAPPMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11128791-B2 | Photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2021-09-21 | — | — | US | disclosed |
| US-10468614-B2 | Photoelectric conversion element, image pick-up element, and image pick-up apparatus | CANON KABUSHIKI KAISHA (JP) | 2019-11-05 | — | — | US | disclosed |
| US-20190267545-A1 | PHOTOELECTRIC CONVERSION ELEMENT, AND IMAGING ELEMENT AND IMAGING APPARATUS INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2019-08-29 | — | — | US | disclosed |
| US-20190267411-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGE PICKUP ELEMENT, AND IMAGE PICKUP APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2019-08-29 | — | — | US | disclosed |
| US-20180138432-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGE PICK-UP ELEMENT, AND IMAGE PICK-UP APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190267545-A1 | PHOTOELECTRIC CONVERSION ELEMENT, AND IMAGING ELEMENT AND IMAGING APPARATUS INCLUDING THE SAME | CPNE4, LEF1, EMC1 | MAPT 2055/4885APP 1499/4885MEN1 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.